Health Care & Life Sciences » Pharmaceuticals | Ascendis Pharma A/S

Ascendis Pharma A/S ADR | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
26,773.60
60,704.60
129,974.70
190,202.00
234,577.40
317,638
Total Accounts Receivable
2,349.40
2,873.90
2,374.70
1,758.30
2,853.10
3,006.50
Other Current Assets
88.20
750.20
4,148.60
2,069.40
8,293.90
14,192.20
Total Current Assets
29,211.20
64,328.70
136,498.00
194,029.70
245,724.40
334,836.70
Net Property, Plant & Equipment
2,720.10
2,267.60
2,558.20
2,478.70
3,070.40
4,944.10
Intangible Assets
4,815.90
4,229.10
3,796.60
3,686.40
4,196.80
3,995.30
Other Assets
44.10
169.40
293.30
282.70
351.80
1,323.80
Total Assets
36,791.30
70,994.80
143,146.10
200,477.30
253,343.50
364,628.30
Accounts Payable
3,472.40
5,997.00
9,095.60
13,794.00
28,540.60
Income Tax Payable
563.60
-
-
301.70
-
Other Current Liabilities
24,072.80
9,565.40
3,337.10
99.10
-
Total Current Liabilities
28,108.80
15,562.40
12,432.70
14,194.80
28,540.60
Total Liabilities
28,108.80
15,562.40
12,432.70
14,194.80
28,540.60
Common Equity (Total)
8,682.50
55,432.40
130,713.40
186,282.50
224,802.90
Total Shareholders' Equity
8,682.50
55,432.40
130,713.40
186,282.50
224,802.90
Total Equity
8,682.50
55,432.40
130,713.40
186,282.50
224,802.90
Liabilities & Shareholders' Equity
36,791.30
70,994.80
143,146.10
200,477.30
253,343.50

About Ascendis Pharma A/S

View Profile
Address
Tuborg Boulevard 12
Hellerup CR 2900
Denmark
Employees -
Website http://www.ascendispharma.com
Updated 07/08/2019
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. Through its TransCon technology, it develops a pipeline of sustained release prodrug therapies including endocrinology product candidates to support the market. The company was founded by Jan Moller Mikkelsen and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.